| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibronectins | 7 | 2009 | 197 | 1.310 |
Why?
|
| Monocytes | 12 | 2009 | 788 | 1.250 |
Why?
|
| HIV-1 | 9 | 2009 | 653 | 0.970 |
Why?
|
| Peptide Fragments | 5 | 2009 | 1271 | 0.730 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2004 | 709 | 0.660 |
Why?
|
| HIV Infections | 9 | 2009 | 2134 | 0.660 |
Why?
|
| Endothelium, Vascular | 8 | 2004 | 891 | 0.600 |
Why?
|
| Antigen-Antibody Complex | 15 | 1995 | 115 | 0.560 |
Why?
|
| Complement C1 | 7 | 1994 | 14 | 0.470 |
Why?
|
| Integrin alpha5 | 2 | 2009 | 15 | 0.430 |
Why?
|
| Lymphocyte Activation | 10 | 2019 | 1688 | 0.390 |
Why?
|
| Lymph | 11 | 2001 | 76 | 0.390 |
Why?
|
| Myocardial Reperfusion | 6 | 1997 | 108 | 0.360 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2014 | 157 | 0.350 |
Why?
|
| Myocardial Ischemia | 6 | 2004 | 435 | 0.350 |
Why?
|
| Complement Activation | 5 | 2014 | 94 | 0.340 |
Why?
|
| Complement Activating Enzymes | 6 | 1989 | 11 | 0.340 |
Why?
|
| Phagocytosis | 5 | 2004 | 260 | 0.310 |
Why?
|
| Neutrophils | 11 | 2001 | 835 | 0.300 |
Why?
|
| Cell Movement | 8 | 2002 | 2466 | 0.290 |
Why?
|
| Computer-Assisted Instruction | 1 | 2007 | 81 | 0.290 |
Why?
|
| Antibodies, Anti-Idiotypic | 8 | 1984 | 101 | 0.280 |
Why?
|
| Emphysema | 2 | 2019 | 87 | 0.280 |
Why?
|
| Complement C1q | 7 | 2019 | 28 | 0.270 |
Why?
|
| Lymphocytes | 14 | 2002 | 1234 | 0.270 |
Why?
|
| Asthma | 2 | 2018 | 871 | 0.260 |
Why?
|
| Complement C5a | 2 | 1997 | 36 | 0.260 |
Why?
|
| Immunoglobulin G | 18 | 2013 | 1021 | 0.260 |
Why?
|
| CD3 Complex | 1 | 2005 | 314 | 0.250 |
Why?
|
| Coronary Disease | 8 | 1992 | 764 | 0.250 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1997 | 362 | 0.230 |
Why?
|
| Dogs | 14 | 2001 | 1155 | 0.220 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 748 | 0.210 |
Why?
|
| Receptors, Complement | 3 | 2014 | 48 | 0.210 |
Why?
|
| Mitochondria, Heart | 2 | 1994 | 72 | 0.210 |
Why?
|
| Immunoglobulin M | 13 | 2013 | 347 | 0.200 |
Why?
|
| Myocardium | 9 | 1997 | 1313 | 0.200 |
Why?
|
| Antibodies, Bacterial | 2 | 2011 | 380 | 0.190 |
Why?
|
| Antigens, CD | 5 | 2004 | 1385 | 0.190 |
Why?
|
| Antibody Formation | 16 | 1995 | 383 | 0.180 |
Why?
|
| Immunoglobulin Fab Fragments | 4 | 1984 | 99 | 0.180 |
Why?
|
| Receptors, Fibronectin | 1 | 1999 | 25 | 0.180 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2009 | 317 | 0.180 |
Why?
|
| Chemokine CCL2 | 2 | 1997 | 203 | 0.170 |
Why?
|
| Arthritis, Rheumatoid | 4 | 1984 | 410 | 0.170 |
Why?
|
| Cocaine-Related Disorders | 2 | 2013 | 231 | 0.170 |
Why?
|
| Leukocytes | 5 | 1997 | 422 | 0.160 |
Why?
|
| Cigarette Smoking | 1 | 2019 | 88 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 284 | 0.160 |
Why?
|
| Th17 Cells | 1 | 2019 | 162 | 0.150 |
Why?
|
| Cystic Fibrosis | 2 | 1990 | 264 | 0.150 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1997 | 72 | 0.150 |
Why?
|
| HLA Antigens | 4 | 1995 | 546 | 0.150 |
Why?
|
| Lung Diseases, Fungal | 1 | 2018 | 124 | 0.150 |
Why?
|
| Reperfusion Injury | 2 | 1998 | 145 | 0.140 |
Why?
|
| Cell Adhesion | 7 | 2004 | 1008 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 2 | 1997 | 461 | 0.140 |
Why?
|
| Bronchodilator Agents | 1 | 2018 | 219 | 0.140 |
Why?
|
| Bartonella | 1 | 1995 | 13 | 0.130 |
Why?
|
| Immunologic Surveillance | 1 | 1995 | 60 | 0.130 |
Why?
|
| Cardiolipins | 1 | 1994 | 33 | 0.130 |
Why?
|
| Reactive Oxygen Species | 3 | 1995 | 987 | 0.130 |
Why?
|
| Flow Cytometry | 6 | 2004 | 3033 | 0.120 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1994 | 50 | 0.120 |
Why?
|
| Coronary Vessels | 3 | 1997 | 665 | 0.120 |
Why?
|
| Antibody Specificity | 4 | 2013 | 334 | 0.120 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 3869 | 0.110 |
Why?
|
| Cholera Vaccines | 1 | 2013 | 5 | 0.110 |
Why?
|
| Measles virus | 1 | 1993 | 15 | 0.110 |
Why?
|
| Cholera Toxin | 1 | 2013 | 63 | 0.110 |
Why?
|
| Humans | 78 | 2019 | 261506 | 0.110 |
Why?
|
| Rabbits | 8 | 1995 | 957 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 2004 | 1073 | 0.110 |
Why?
|
| Measles | 1 | 1993 | 36 | 0.110 |
Why?
|
| Immune Tolerance | 3 | 2019 | 403 | 0.110 |
Why?
|
| Glomerulonephritis | 3 | 1979 | 109 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 3 | 2001 | 197 | 0.110 |
Why?
|
| Macrophages | 4 | 2004 | 1304 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2018 | 834 | 0.100 |
Why?
|
| CD18 Antigens | 5 | 1998 | 83 | 0.100 |
Why?
|
| Complement System Proteins | 5 | 1995 | 139 | 0.100 |
Why?
|
| Integrins | 2 | 1993 | 262 | 0.100 |
Why?
|
| Immunoglobulin A | 5 | 1989 | 237 | 0.100 |
Why?
|
| Cocaine | 1 | 2013 | 233 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 1997 | 1130 | 0.100 |
Why?
|
| Arthritis, Juvenile | 2 | 1982 | 51 | 0.100 |
Why?
|
| gamma-Globulins | 10 | 1970 | 21 | 0.100 |
Why?
|
| Pancreatic Elastase | 1 | 1990 | 34 | 0.090 |
Why?
|
| Gene Expression Regulation | 4 | 2014 | 4053 | 0.090 |
Why?
|
| Male | 44 | 2019 | 123000 | 0.090 |
Why?
|
| Hypergammaglobulinemia | 1 | 1989 | 19 | 0.090 |
Why?
|
| Collagen Type II | 1 | 2010 | 41 | 0.090 |
Why?
|
| Cartilage, Articular | 1 | 2010 | 75 | 0.090 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1997 | 849 | 0.090 |
Why?
|
| Immunotherapy, Active | 1 | 2009 | 46 | 0.090 |
Why?
|
| Pneumococcal Vaccines | 1 | 2011 | 161 | 0.090 |
Why?
|
| Hyaluronan Receptors | 2 | 1988 | 249 | 0.090 |
Why?
|
| Complement Pathway, Classical | 1 | 1989 | 7 | 0.090 |
Why?
|
| Animals | 30 | 2019 | 59536 | 0.090 |
Why?
|
| Antibodies | 12 | 1994 | 838 | 0.090 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2009 | 297 | 0.090 |
Why?
|
| Pulmonary Alveoli | 1 | 1990 | 208 | 0.080 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 168 | 0.080 |
Why?
|
| Methadone | 1 | 2009 | 195 | 0.080 |
Why?
|
| Pokeweed Mitogens | 2 | 1984 | 9 | 0.080 |
Why?
|
| Osteoarthritis, Knee | 1 | 2010 | 162 | 0.080 |
Why?
|
| Viral Load | 1 | 2009 | 493 | 0.080 |
Why?
|
| Adult | 30 | 2019 | 77950 | 0.080 |
Why?
|
| HLA-DR Antigens | 2 | 2004 | 173 | 0.070 |
Why?
|
| Computers | 1 | 2007 | 141 | 0.070 |
Why?
|
| Mucus | 7 | 1970 | 119 | 0.070 |
Why?
|
| Leucine | 2 | 2005 | 352 | 0.070 |
Why?
|
| Extracellular Matrix | 2 | 2001 | 554 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 1992 | 577 | 0.070 |
Why?
|
| Cells, Cultured | 8 | 2019 | 5637 | 0.070 |
Why?
|
| Cytotoxins | 3 | 1983 | 66 | 0.070 |
Why?
|
| Phagocytes | 2 | 1997 | 44 | 0.070 |
Why?
|
| Cause of Death | 1 | 2009 | 752 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2004 | 1538 | 0.070 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 1984 | 47 | 0.070 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2005 | 86 | 0.070 |
Why?
|
| Smoking | 1 | 2014 | 2440 | 0.070 |
Why?
|
| CD11 Antigens | 3 | 1998 | 23 | 0.060 |
Why?
|
| In Vitro Techniques | 4 | 1999 | 1618 | 0.060 |
Why?
|
| Lymphokines | 1 | 1985 | 272 | 0.060 |
Why?
|
| Growth Substances | 1 | 1985 | 300 | 0.060 |
Why?
|
| Medication Adherence | 1 | 2009 | 492 | 0.060 |
Why?
|
| B7-2 Antigen | 1 | 2004 | 55 | 0.060 |
Why?
|
| L-Selectin | 1 | 2004 | 34 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2004 | 66 | 0.060 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2004 | 97 | 0.060 |
Why?
|
| Myeloblastin | 1 | 2004 | 64 | 0.060 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2004 | 60 | 0.060 |
Why?
|
| Hemocyanins | 1 | 1983 | 50 | 0.060 |
Why?
|
| Immunoglobulins | 4 | 1979 | 266 | 0.060 |
Why?
|
| Neurons | 1 | 1994 | 2287 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2009 | 3536 | 0.060 |
Why?
|
| Coronary Circulation | 3 | 1997 | 253 | 0.060 |
Why?
|
| Sputum | 2 | 2018 | 141 | 0.060 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 275 | 0.060 |
Why?
|
| Female | 27 | 2019 | 141928 | 0.060 |
Why?
|
| Leukocyte Count | 3 | 2018 | 684 | 0.060 |
Why?
|
| Streptodornase and Streptokinase | 1 | 1982 | 2 | 0.050 |
Why?
|
| Serum Albumin | 7 | 1985 | 257 | 0.050 |
Why?
|
| Staphylococcal Protein A | 1 | 1981 | 18 | 0.050 |
Why?
|
| Immune Complex Diseases | 2 | 1979 | 12 | 0.050 |
Why?
|
| Prognosis | 9 | 2009 | 21713 | 0.050 |
Why?
|
| Middle Aged | 15 | 2019 | 86204 | 0.050 |
Why?
|
| Complement C3 | 3 | 2014 | 78 | 0.050 |
Why?
|
| Antigens | 5 | 1971 | 292 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 1997 | 846 | 0.050 |
Why?
|
| Transplantation Immunology | 5 | 1974 | 97 | 0.050 |
Why?
|
| Time Factors | 8 | 1998 | 12926 | 0.050 |
Why?
|
| Cell Line | 5 | 1994 | 5114 | 0.050 |
Why?
|
| Software | 1 | 2007 | 1321 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2004 | 1681 | 0.040 |
Why?
|
| Cell Survival | 3 | 2004 | 3045 | 0.040 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2001 | 360 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 1985 | 1294 | 0.040 |
Why?
|
| Lung | 4 | 2019 | 3151 | 0.040 |
Why?
|
| Adolescent | 8 | 2009 | 31252 | 0.040 |
Why?
|
| Periodontal Diseases | 1 | 1979 | 22 | 0.040 |
Why?
|
| Aged | 10 | 2019 | 70117 | 0.040 |
Why?
|
| Smoke | 1 | 2019 | 60 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 671 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 2594 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 208 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 764 | 0.040 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2018 | 23 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1989 | 629 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 1479 | 0.040 |
Why?
|
| Microcirculation | 1 | 1998 | 200 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2004 | 1085 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2019 | 120 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 4938 | 0.040 |
Why?
|
| Integrin alpha4 | 1 | 1997 | 25 | 0.040 |
Why?
|
| Immunity, Cellular | 5 | 1989 | 419 | 0.040 |
Why?
|
| Cytokines | 2 | 1998 | 2809 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2019 | 626 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 8 | 1975 | 1062 | 0.040 |
Why?
|
| Sarcolemma | 2 | 1994 | 32 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2019 | 263 | 0.040 |
Why?
|
| Ultracentrifugation | 8 | 1983 | 46 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2007 | 16273 | 0.040 |
Why?
|
| Respiratory System | 1 | 2018 | 125 | 0.040 |
Why?
|
| Protein Binding | 3 | 1994 | 3438 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 760 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 5710 | 0.040 |
Why?
|
| Eosinophils | 1 | 2018 | 162 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 1998 | 221 | 0.040 |
Why?
|
| Extracellular Space | 1 | 1997 | 132 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 1997 | 126 | 0.040 |
Why?
|
| Head and Neck Neoplasms | 2 | 1989 | 3976 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 6089 | 0.040 |
Why?
|
| Immune Sera | 5 | 1992 | 146 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 1077 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1989 | 5437 | 0.030 |
Why?
|
| Chemotactic Factors | 2 | 1992 | 42 | 0.030 |
Why?
|
| Child | 6 | 2007 | 29154 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1999 | 4233 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 1995 | 18 | 0.030 |
Why?
|
| Respiratory Burst | 1 | 1995 | 23 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2013 | 2588 | 0.030 |
Why?
|
| Proteus Infections | 1 | 1975 | 3 | 0.030 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 18 | 0.030 |
Why?
|
| Binding, Competitive | 3 | 1984 | 300 | 0.030 |
Why?
|
| Complement C3a | 1 | 2014 | 18 | 0.030 |
Why?
|
| Urease | 1 | 1975 | 60 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1994 | 8 | 0.030 |
Why?
|
| Phospholipases | 1 | 1994 | 13 | 0.030 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 40 | 0.030 |
Why?
|
| Pyelonephritis | 1 | 1975 | 39 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 673 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 2014 | 84 | 0.030 |
Why?
|
| Kinetics | 3 | 1992 | 2049 | 0.030 |
Why?
|
| Leukocyte Elastase | 1 | 2014 | 70 | 0.030 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 1994 | 62 | 0.030 |
Why?
|
| Immunoelectrophoresis | 8 | 1975 | 40 | 0.030 |
Why?
|
| HIV Core Protein p24 | 1 | 1994 | 20 | 0.030 |
Why?
|
| Audiometry, Pure-Tone | 1 | 1994 | 32 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 23 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2014 | 128 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 7222 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 7 | 1981 | 124 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1990 | 600 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 2074 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 1994 | 118 | 0.030 |
Why?
|
| Antilymphocyte Serum | 2 | 1971 | 228 | 0.030 |
Why?
|
| Cell Aggregation | 1 | 1993 | 61 | 0.030 |
Why?
|
| Phenotype | 2 | 1995 | 6295 | 0.030 |
Why?
|
| Immunochemistry | 1 | 1992 | 61 | 0.030 |
Why?
|
| Reaction Time | 1 | 1994 | 234 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 2 | 1990 | 67 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 1973 | 193 | 0.030 |
Why?
|
| Receptors, Leukocyte-Adhesion | 2 | 1989 | 13 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 370 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1992 | 55 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1995 | 435 | 0.030 |
Why?
|
| Culture Media | 1 | 1993 | 319 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 1993 | 291 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 1994 | 4367 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 1975 | 442 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 1997 | 1033 | 0.030 |
Why?
|
| Inflammation | 3 | 2004 | 2522 | 0.030 |
Why?
|
| Immunoglobulin Idiotypes | 2 | 1983 | 51 | 0.030 |
Why?
|
| Salmonella typhi | 3 | 1967 | 15 | 0.030 |
Why?
|
| Cell Communication | 1 | 1994 | 509 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 261 | 0.020 |
Why?
|
| Genes, MHC Class II | 2 | 1982 | 67 | 0.020 |
Why?
|
| Endotoxins | 3 | 1971 | 96 | 0.020 |
Why?
|
| Antigens, Differentiation | 2 | 1989 | 238 | 0.020 |
Why?
|
| Melanoma | 4 | 1983 | 5317 | 0.020 |
Why?
|
| Precipitin Tests | 3 | 1983 | 329 | 0.020 |
Why?
|
| Rhinovirus | 3 | 1970 | 94 | 0.020 |
Why?
|
| Dimercaprol | 1 | 1990 | 4 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 1990 | 61 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 1975 | 321 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 1992 | 519 | 0.020 |
Why?
|
| HLA-DR3 Antigen | 1 | 1989 | 3 | 0.020 |
Why?
|
| HLA-DR2 Antigen | 1 | 1989 | 10 | 0.020 |
Why?
|
| Heart Transplantation | 4 | 1971 | 908 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 1982 | 88 | 0.020 |
Why?
|
| Injections, Intra-Articular | 1 | 2010 | 32 | 0.020 |
Why?
|
| Common Cold | 2 | 1967 | 46 | 0.020 |
Why?
|
| Aging | 1 | 1979 | 1582 | 0.020 |
Why?
|
| Rheumatoid Factor | 2 | 1982 | 10 | 0.020 |
Why?
|
| Proteins | 3 | 1966 | 1963 | 0.020 |
Why?
|
| Transferrin | 2 | 1966 | 78 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1982 | 512 | 0.020 |
Why?
|
| Complement Fixation Tests | 1 | 1989 | 38 | 0.020 |
Why?
|
| Substance Abuse Detection | 1 | 2009 | 64 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 6100 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1994 | 898 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 1994 | 500 | 0.020 |
Why?
|
| Interleukin-6 | 2 | 1992 | 1038 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 241 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1990 | 461 | 0.020 |
Why?
|
| Parotid Gland | 2 | 1968 | 112 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1995 | 1146 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 568 | 0.020 |
Why?
|
| Nasal Polyps | 1 | 1968 | 27 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1988 | 293 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1990 | 233 | 0.020 |
Why?
|
| Palatine Tonsil | 1 | 1968 | 53 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2019 | 4078 | 0.020 |
Why?
|
| Mitochondrial Proteins | 2 | 1988 | 369 | 0.020 |
Why?
|
| Nervous System | 1 | 1989 | 165 | 0.020 |
Why?
|
| Chromatography, Gel | 6 | 1979 | 157 | 0.020 |
Why?
|
| Salivary Glands | 1 | 1968 | 130 | 0.020 |
Why?
|
| Diphtheria Toxoid | 2 | 1981 | 12 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 4320 | 0.020 |
Why?
|
| Spleen | 3 | 2004 | 676 | 0.020 |
Why?
|
| Calcium | 1 | 1993 | 1537 | 0.020 |
Why?
|
| Pedigree | 2 | 1982 | 1890 | 0.020 |
Why?
|
| Kidney Glomerulus | 2 | 1979 | 156 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 5159 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 7226 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 1489 | 0.020 |
Why?
|
| Apoptosis | 2 | 2004 | 7591 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1985 | 18 | 0.020 |
Why?
|
| Leukemia | 3 | 1984 | 1635 | 0.020 |
Why?
|
| Binding Sites | 2 | 1989 | 2171 | 0.020 |
Why?
|
| Trypsin | 1 | 1985 | 140 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 1990 | 548 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 7548 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 2307 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 1985 | 284 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1989 | 549 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1966 | 294 | 0.020 |
Why?
|
| Isoantigens | 1 | 1984 | 62 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 394 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 1985 | 264 | 0.020 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1984 | 17 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1985 | 276 | 0.020 |
Why?
|
| Haploidy | 1 | 1984 | 40 | 0.020 |
Why?
|
| HLA-B Antigens | 1 | 1984 | 57 | 0.020 |
Why?
|
| Prospective Studies | 2 | 1994 | 12873 | 0.020 |
Why?
|
| Biological Factors | 1 | 2004 | 45 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 1984 | 91 | 0.020 |
Why?
|
| Nose | 1 | 1966 | 192 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1983 | 191 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 148 | 0.010 |
Why?
|
| Mollusca | 1 | 1983 | 11 | 0.010 |
Why?
|
| Pneumonia | 1 | 1990 | 751 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 3154 | 0.010 |
Why?
|
| Methods | 2 | 1981 | 189 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 328 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 2803 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 1982 | 46 | 0.010 |
Why?
|
| Chromatography, Agarose | 1 | 1981 | 4 | 0.010 |
Why?
|
| Immunosorbents | 1 | 1981 | 10 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1989 | 1374 | 0.010 |
Why?
|
| Ammonium Sulfate | 1 | 1981 | 8 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1985 | 842 | 0.010 |
Why?
|
| Goats | 1 | 1981 | 73 | 0.010 |
Why?
|
| Carrier Proteins | 2 | 1988 | 2022 | 0.010 |
Why?
|
| Sepharose | 1 | 1981 | 32 | 0.010 |
Why?
|
| Patient Selection | 1 | 2010 | 2055 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1984 | 417 | 0.010 |
Why?
|
| Neoplasms | 2 | 1979 | 15193 | 0.010 |
Why?
|
| Immunization | 1 | 1983 | 397 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1985 | 1144 | 0.010 |
Why?
|
| Rats | 2 | 2004 | 6086 | 0.010 |
Why?
|
| Macrophage-1 Antigen | 2 | 1992 | 51 | 0.010 |
Why?
|
| Gene Frequency | 1 | 1984 | 1163 | 0.010 |
Why?
|
| Adenoviridae | 1 | 1966 | 1459 | 0.010 |
Why?
|
| Antibodies, Neoplasm | 1 | 1982 | 259 | 0.010 |
Why?
|
| Iodine Isotopes | 4 | 1973 | 11 | 0.010 |
Why?
|
| Cytoplasmic Granules | 1 | 2001 | 89 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1982 | 447 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1984 | 1471 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 29902 | 0.010 |
Why?
|
| Gingivitis | 1 | 1979 | 5 | 0.010 |
Why?
|
| Periodontitis | 1 | 1979 | 18 | 0.010 |
Why?
|
| Transplantation, Homologous | 5 | 1974 | 2843 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 2063 | 0.010 |
Why?
|
| Aluminum Silicates | 2 | 1970 | 15 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 1980 | 331 | 0.010 |
Why?
|
| Solubility | 2 | 1977 | 242 | 0.010 |
Why?
|
| Mice | 3 | 2019 | 34495 | 0.010 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1998 | 72 | 0.010 |
Why?
|
| Blood | 1 | 1979 | 156 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 1998 | 151 | 0.010 |
Why?
|
| Nasal Mucosa | 3 | 1967 | 94 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 1967 | 159 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 1998 | 112 | 0.010 |
Why?
|
| Fetus | 1 | 1982 | 601 | 0.010 |
Why?
|
| Osteopontin | 1 | 1998 | 148 | 0.010 |
Why?
|
| Biomarkers | 1 | 2010 | 5047 | 0.010 |
Why?
|
| Antigens, Neoplasm | 3 | 1973 | 1506 | 0.010 |
Why?
|
| Histamine Release | 1 | 1997 | 15 | 0.010 |
Why?
|
| Base Sequence | 2 | 1997 | 4917 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 1981 | 615 | 0.010 |
Why?
|
| Neutralization Tests | 3 | 1967 | 299 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 2437 | 0.010 |
Why?
|
| Collagen | 1 | 2001 | 752 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1977 | 43 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 1764 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1980 | 613 | 0.010 |
Why?
|
| Mast Cells | 1 | 1998 | 223 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1976 | 54 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1984 | 1960 | 0.010 |
Why?
|
| Cell Membrane | 4 | 1975 | 850 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 14889 | 0.010 |
Why?
|
| Jugular Veins | 1 | 1997 | 107 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1979 | 223 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.010 |
Why?
|
| Isoantibodies | 2 | 1974 | 115 | 0.010 |
Why?
|
| Kidney | 2 | 1975 | 2146 | 0.010 |
Why?
|
| Veins | 1 | 1997 | 157 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 1979 | 280 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 1998 | 478 | 0.010 |
Why?
|
| Latex Fixation Tests | 1 | 1975 | 10 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1975 | 67 | 0.010 |
Why?
|
| Tears | 2 | 1967 | 181 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 2 | 1973 | 276 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 37905 | 0.010 |
Why?
|
| Acute Disease | 2 | 1984 | 2422 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1975 | 192 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1979 | 677 | 0.010 |
Why?
|
| Immunoassay | 1 | 1975 | 216 | 0.010 |
Why?
|
| Azathioprine | 2 | 1971 | 66 | 0.010 |
Why?
|
| Adsorption | 2 | 1971 | 46 | 0.010 |
Why?
|
| Creatinine | 1 | 1976 | 531 | 0.010 |
Why?
|
| Histocompatibility | 2 | 1971 | 168 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1975 | 585 | 0.010 |
Why?
|
| Immunodiffusion | 3 | 1970 | 46 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1973 | 74 | 0.010 |
Why?
|
| Cats | 1 | 1993 | 166 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1973 | 191 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1973 | 231 | 0.010 |
Why?
|
| Sex Factors | 1 | 1979 | 2139 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1993 | 333 | 0.010 |
Why?
|
| Kidney Transplantation | 3 | 1974 | 755 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1992 | 113 | 0.010 |
Why?
|
| Heart | 1 | 1998 | 1223 | 0.010 |
Why?
|
| Rodent Diseases | 1 | 1971 | 29 | 0.010 |
Why?
|
| Cell Separation | 1 | 1993 | 612 | 0.010 |
Why?
|
| Technetium | 1 | 1991 | 77 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1977 | 1910 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1992 | 279 | 0.010 |
Why?
|
| Chemistry | 2 | 1970 | 99 | 0.010 |
Why?
|
| Chemical Phenomena | 2 | 1970 | 137 | 0.010 |
Why?
|
| Lymphoma | 2 | 1977 | 1467 | 0.010 |
Why?
|
| Fluoresceins | 1 | 1970 | 73 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1970 | 128 | 0.010 |
Why?
|
| Malaria | 1 | 1971 | 92 | 0.010 |
Why?
|
| Biological Transport | 1 | 1992 | 597 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1991 | 660 | 0.010 |
Why?
|
| Plasmids | 1 | 1992 | 837 | 0.010 |
Why?
|
| Muscles | 1 | 1971 | 416 | 0.010 |
Why?
|
| Orthomyxoviridae | 2 | 1967 | 94 | 0.010 |
Why?
|
| Models, Biological | 1 | 1998 | 3254 | 0.010 |
Why?
|
| DNA, Viral | 1 | 1992 | 694 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 717 | 0.010 |
Why?
|
| Tritium | 3 | 1974 | 200 | 0.010 |
Why?
|
| Thymidine | 3 | 1974 | 155 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 2 | 1982 | 84 | 0.010 |
Why?
|
| Recurrence | 1 | 1977 | 4758 | 0.010 |
Why?
|
| Body Weight | 1 | 1973 | 1293 | 0.010 |
Why?
|
| Virus Replication | 1 | 1992 | 709 | 0.010 |
Why?
|
| Homeostasis | 1 | 1993 | 950 | 0.010 |
Why?
|
| Bleomycin | 1 | 1989 | 467 | 0.000 |
Why?
|
| Lung Neoplasms | 4 | 1982 | 11538 | 0.000 |
Why?
|
| Kaolin | 1 | 1967 | 4 | 0.000 |
Why?
|
| Reoviridae | 1 | 1967 | 38 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1993 | 1467 | 0.000 |
Why?
|
| Biopsy | 1 | 1975 | 3443 | 0.000 |
Why?
|
| Haplorhini | 1 | 1967 | 130 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1989 | 15862 | 0.000 |
Why?
|
| Cyclophosphamide | 2 | 1971 | 3001 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 3 | 1970 | 92 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1997 | 6150 | 0.000 |
Why?
|
| Cross Reactions | 2 | 1982 | 266 | 0.000 |
Why?
|
| Muramidase | 1 | 1966 | 110 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1992 | 1620 | 0.000 |
Why?
|
| Respiratory Tract Infections | 1 | 1970 | 437 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1967 | 252 | 0.000 |
Why?
|
| Saliva | 1 | 1966 | 231 | 0.000 |
Why?
|
| Albumins | 1 | 1966 | 258 | 0.000 |
Why?
|
| Lipopolysaccharides | 1 | 1967 | 558 | 0.000 |
Why?
|
| Fluorouracil | 1 | 1989 | 1944 | 0.000 |
Why?
|
| Glioma | 1 | 1976 | 1963 | 0.000 |
Why?
|
| Multiple Myeloma | 1 | 1976 | 2138 | 0.000 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1984 | 50 | 0.000 |
Why?
|
| Breast Neoplasms | 3 | 1982 | 15694 | 0.000 |
Why?
|
| Pancreas | 1 | 1968 | 718 | 0.000 |
Why?
|
| Liver | 2 | 1975 | 2961 | 0.000 |
Why?
|
| Lectins | 2 | 1973 | 151 | 0.000 |
Why?
|
| Lymph Nodes | 2 | 1975 | 2967 | 0.000 |
Why?
|
| Cisplatin | 1 | 1989 | 2432 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1967 | 1203 | 0.000 |
Why?
|
| Cattle | 1 | 1982 | 783 | 0.000 |
Why?
|
| Sheep | 2 | 1970 | 258 | 0.000 |
Why?
|
| Erythrocytes | 2 | 1971 | 339 | 0.000 |
Why?
|
| Influenza, Human | 1 | 1967 | 925 | 0.000 |
Why?
|
| Bone Marrow | 1 | 1984 | 2358 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1973 | 6915 | 0.000 |
Why?
|
| Methylmannosides | 1 | 1975 | 2 | 0.000 |
Why?
|
| Chromium Radioisotopes | 1 | 1975 | 9 | 0.000 |
Why?
|
| Whole-Body Counting | 1 | 1975 | 27 | 0.000 |
Why?
|
| Iodine Radioisotopes | 1 | 1975 | 371 | 0.000 |
Why?
|
| Serotyping | 1 | 1973 | 166 | 0.000 |
Why?
|
| Eggs | 1 | 1973 | 24 | 0.000 |
Why?
|
| Twins | 1 | 1973 | 70 | 0.000 |
Why?
|
| ABO Blood-Group System | 1 | 1973 | 127 | 0.000 |
Why?
|
| Remission, Spontaneous | 1 | 1973 | 119 | 0.000 |
Why?
|
| Skin Tests | 1 | 1973 | 96 | 0.000 |
Why?
|
| Streptolysins | 1 | 1971 | 7 | 0.000 |
Why?
|
| Antibody-Producing Cells | 1 | 1971 | 15 | 0.000 |
Why?
|
| Quinacrine | 1 | 1971 | 7 | 0.000 |
Why?
|
| Plasmodium | 1 | 1971 | 8 | 0.000 |
Why?
|
| Autoradiography | 1 | 1971 | 132 | 0.000 |
Why?
|
| Culture Techniques | 1 | 1971 | 132 | 0.000 |
Why?
|
| Bence Jones Protein | 1 | 1970 | 10 | 0.000 |
Why?
|
| Thiocyanates | 1 | 1970 | 17 | 0.000 |
Why?
|
| Coxsackievirus Infections | 1 | 1970 | 17 | 0.000 |
Why?
|
| Horses | 1 | 1970 | 96 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1975 | 2314 | 0.000 |
Why?
|
| Hemagglutination Tests | 1 | 1970 | 33 | 0.000 |
Why?
|
| Tannins | 1 | 1970 | 5 | 0.000 |
Why?
|
| Chemical Precipitation | 1 | 1970 | 23 | 0.000 |
Why?
|
| Aluminum | 1 | 1970 | 19 | 0.000 |
Why?
|
| Injections, Intramuscular | 1 | 1970 | 255 | 0.000 |
Why?
|
| Autoantibodies | 1 | 1973 | 576 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1970 | 429 | 0.000 |
Why?
|
| Immunity | 1 | 1971 | 342 | 0.000 |
Why?
|
| Hemadsorption Inhibition Tests | 1 | 1967 | 1 | 0.000 |
Why?
|
| Absorption | 1 | 1967 | 81 | 0.000 |
Why?
|
| Manganese | 1 | 1967 | 80 | 0.000 |
Why?
|
| Chlorides | 1 | 1967 | 139 | 0.000 |
Why?
|
| Graft Rejection | 1 | 1971 | 834 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1976 | 5112 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1971 | 1819 | 0.000 |
Why?
|
| Heparin | 1 | 1967 | 360 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1975 | 6942 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1970 | 1375 | 0.000 |
Why?
|
| Pregnancy | 1 | 1973 | 7573 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1970 | 5542 | 0.000 |
Why?
|